Home > Financial Ratios > AARTI PHARMALABS

AARTI PHARMALABS
Price to Cash Earnings (PCE)

    Back to All Ratios
AD     Remove this Ad

AARTI PHARMALABS Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   PCE(x) 18.8813.599.72--

What is the latest Price to Cash Earnings (PCE) ratio of AARTI PHARMALABS ?

The latest Price to Cash Earnings (PCE) ratio of AARTI PHARMALABS is 18.88 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202518.88
Mar202413.59
Mar20239.72
Mar2022-
Mar2021-

How is Price to Cash Earnings (PCE) of AARTI PHARMALABS Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 18.88
38.93
Mar2024 13.59
39.81
Mar2023 9.72
0
Mar2022 0
0
Mar2021 0 -

Other Financial Ratios of AARTI PHARMALABS


Compare Price to Cash Earnings (PCE) ratio of peers of AARTI PHARMALABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI PHARMALABS ₹6,292.3 Cr 6.1% 1.1% -15.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹396,370.0 Cr -2.3% -8.5% -3% Stock Analytics
DIVIS LABORATORIES ₹161,193.0 Cr 5.3% -3.4% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹141,438.0 Cr 3.7% -4.9% 26% Stock Analytics
DR REDDYS LABORATORIES ₹103,097.0 Cr 1.2% -4.2% 5.3% Stock Analytics
CIPLA ₹97,846.7 Cr 2.4% -7.2% -18.1% Stock Analytics


AARTI PHARMALABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI PHARMALABS

6.1%

1.1%

-15.5%

SENSEX

3.7%

-0.9%

0.7%


You may also like the below Video Courses